Healing of Persistent Epithelial Defects

NCT02395952 — Not applicable, Withdrawn, Milton S. Hershey Medical Center

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comparison of Standard of Care Treatments for Post-operative Non-healing Epithelial Defects

RegistryNCT02395952
StatusWithdrawn - No patients recruited
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
SponsorMilton S. Hershey Medical Center (Other)
ConditionsCornea
Interventionscarboxymethylcellulose sodium, Acuvue Oasys Bandage Contact Lens, Ambiodisk, Prokera (Drug, device)
Datesstart 2015-03-01, primary completion 2018-02-01, completion 2018-02-01, first posted 2015-03-24, last updated 2019-02-05
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Cornea All trials of carboxymethylcellulose sodium All trials of Acuvue Oasys Bandage Contact Lens

-Summary

The purpose of this study is to compare the relative efficacy of four different treatment modalities (i.e. aggressive lubrication, bandage contact lens, Ambiodisk amniotic membrane, Prokera amniotic membrane) in the healing of persistent corneal epithelial defects following retina surgery.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
LubricationActive comparatorDrug: carboxymethylcellulose sodium
Bandage Contact LensActive comparatorDevice: Acuvue Oasys Bandage Contact LensAcuvue Oasys Contact Lens
ProkeraActive comparatorDevice: ProkeraWet amniotic membrane mounted on plastic retaining ring
AmbiodiskActive comparatorDevice: AmbiodiskFreeze dried amniotic membrane
  • carboxymethylcellulose sodium (Drug): frequent topical lubrication with artificial tears
  • Acuvue Oasys Bandage Contact Lens (Device)
  • Ambiodisk (Device)
  • Prokera (Device)

+Outcome measures

Primary outcomes

  • Abscence of persistent epithelial defect [22 days]

Secondary outcomes

  • Rate of epithelial healing in mm2/day [22 days]
  • Infection [22 days]

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

3.1 Inclusion Criteria

* Adults aged 18 and older (inclusive) at the time of study enrollment
* Recent history of retina surgery
* Presence of persistent epithelial defect 7 days or later after surgery
* English speaking

3.2 Exclusion Criteria

* Non-English speaking patients
* Inability to incapacity to provide consent for the study
* History of corneal epithelial or limbal stem cell disease

+Locations (1)

FacilityCityCountryStatus
Penn State Hershey Eye CenterHershey, PennsylvaniaUnited States